Table 5.
Adverse events by treatment groups
| Outcome Variable | n (%) | P Value | |
|---|---|---|---|
| Placebo (n=140) | Lanthanum (n=138) | ||
| Any SAE | 66 (47) | 61 (44) | 0.62 |
| Death from any cause | 8 (6) | 2 (1) | 0.10a |
| Life-threatening event | 0 | 4 (3) | 0.06a |
| Initial or prolonged inpatient hospitalization | 64 (46) | 58 (42) | 0.54 |
| Persistent/significant disability | 1 (<1) | 2 (1) | 0.62a |
| Important medical event | 7 (5) | 8 (6) | 0.77 |
| Any adverse drug reaction | 16 (11) | 18 (13) | 0.68 |
| Gastrointestinal eventb | 10 (7) | 8 (6) | 0.65 |
| Nausea/vomiting | 4 (3) | 6 (4) | 0.54a |
| Other event | 6 (4) | 4 (3) | 0.75a |
SAE, serious adverse event.
Fisher exact test.
Includes diarrhea, constipation, gastroesophageal reflux.